<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2022.80.26</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-324</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Роль нейропилина-1 (NRP1) в развитии инфекции SARS-CoV-2</article-title><trans-title-group xml:lang="en"><trans-title>The role of neuropilin-1 (NRP1) in the development of SARS-CoV-2 infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркелов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Markelov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркелов Виталий Андреевич – магистрант ФГБОУ ВО БашГУ; ст. лаборант ФГБОУ ВО БГМУ </p></bio><bio xml:lang="en"><p>Markelov Vitaly Andreevich – graduate student of the FSBEI HE Bashkir State University; senior laboratory assistant of the FSBEI HE Bashkir State Medical University </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилко</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Данилко Ксения Владимировна – к.б.н., доцент ФГБОУ ВО БГМУ Минздрава России, с.н.с. ЦНИЛ ФГБОУ ВО БГМУ</p></bio><bio xml:lang="en"><p>Danilko Ksenia Vladimirovna – PhD, Associate Professor of the FSBEI HE Bashkir State Medical University of the Ministry of Health of Russia, senior researcher of the Central Research Institute </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО БашГУ; &#13;
ФГБОУ ВО БГМУ Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBEI HE Bashkir State Universityж &#13;
FSBEI HE Bashkir State Medical University of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО БГМУ Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBEI HE Bashkir State Medical University of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>02</month><year>2025</year></pub-date><volume>0</volume><issue>4</issue><fpage>101</fpage><lpage>103</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Маркелов В.А., Данилко К.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Маркелов В.А., Данилко К.В.</copyright-holder><copyright-holder xml:lang="en">Markelov V.A., Danilko A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/324">https://ymj.elpub.ru/jour/article/view/324</self-uri><abstract><p>Представлен обзор литературы о роли нейропилина-1 в развитии инфекции SARS-CoV-2 и поиск вероятных связей полиморфных вариантов гена NRP1 c SARS-CoV-2. В данном обзоре приведены характеристики полиморфных вариантов гена NRP1, которые демонстрируют возможность их связи с течением инфекции SARS-CoV-2.</p></abstract><trans-abstract xml:lang="en"><p>A review of the literature on the role of neuropilin-1 in the development of SARS-CoV-2 infection and a search for probable links between polymorphic variants of the NRP1 gene and SARS-CoV-2 are presented. This review presents the characteristics of polymorphic variants of the NRP1 gene, which demonstrate the possibility of their association with the course of SARS-CoV-2 infection.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекция SARS-CoV-2</kwd><kwd>нейропилин-1</kwd><kwd>полиморфные варианты гена NRP1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SARS-CoV-2 infection</kwd><kwd>neuropilin-1</kwd><kwd>polymorphic variants of the NRP1 gene</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке программы стратегического академического лидерства «Приоритет 2030».</funding-statement><funding-statement xml:lang="en">The work was supported by the strategic academic leadership «Program Priority 2030».</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020 Jul 9; 383(2):120-128. doi: 10.1056/NEJMoa2015432.</mixed-citation><mixed-citation xml:lang="en">Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020 Jul 9; 383(2):120-128. doi: 10.1056/NEJMoa2015432.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alnomasy SF. Virus-receptor interactions of SARS-CoV-2 spike receptor-binding domain and human neuropilin-1 b1 domain. Saudi J Biol Sci. 2021 Jul; 28(7):3926-3928. doi: 10.1016/j.sjbs.2021.03.074.</mixed-citation><mixed-citation xml:lang="en">Alnomasy SF. Virus-receptor interactions of SARS-CoV-2 spike receptor-binding domain and human neuropilin-1 b1 domain. Saudi J Biol Sci. 2021 Jul; 28(7):3926-3928. doi: 10.1016/j.sjbs.2021.03.074.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Burks SM, Rosas-Hernandez H, Alejandro Ramirez-Lee M, et al. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav Immun. 2021 Jul;95:7-14. doi: 10.1016/j.bbi.2020.12.031.</mixed-citation><mixed-citation xml:lang="en">Burks SM, Rosas-Hernandez H, Alejandro Ramirez-Lee M, et al. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav Immun. 2021 Jul;95:7-14. doi: 10.1016/j.bbi.2020.12.031.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020 Dec;146:105131. doi: 10.1016/j.nbd.2020.105131.</mixed-citation><mixed-citation xml:lang="en">Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020 Dec;146:105131. doi: 10.1016/j.nbd.2020.105131.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bruder D, Probst-Kepper M, Westendorf AM, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol. 2004 Mar;34(3):623-630. doi: 10.1002/eji.200324799.</mixed-citation><mixed-citation xml:lang="en">Bruder D, Probst-Kepper M, Westendorf AM, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol. 2004 Mar;34(3):623-630. doi: 10.1002/eji.200324799.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985.</mixed-citation><mixed-citation xml:lang="en">Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020 Nov 13;370(6518):861865. doi: 10.1126/science.abd3072.</mixed-citation><mixed-citation xml:lang="en">Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Duran I, Tenney J, Warren CM, et al. NRP1 haploinsufficiency predisposes to the development of Tetralogy of Fallot. Am J Med Genet A. 2018 Mar;176(3):649-656. doi: 10.1002/ajmg.a.38600.</mixed-citation><mixed-citation xml:lang="en">Duran I, Tenney J, Warren CM, et al. NRP1 haploinsufficiency predisposes to the development of Tetralogy of Fallot. Am J Med Genet A. 2018 Mar;176(3):649-656. doi: 10.1002/ajmg.a.38600.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Girija ASS. Fox3+ CD25+ CD4+ T-regulatory cells may transform the nCoV's final destiny to CNS! J Med Virol. 2021 Oct;93(10):5673-5675. doi: 10.1002/jmv.26482.</mixed-citation><mixed-citation xml:lang="en">Girija ASS. Fox3+ CD25+ CD4+ T-regulatory cells may transform the nCoV's final destiny to CNS! J Med Virol. 2021 Oct;93(10):56735675. doi: 10.1002/jmv.26482.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gerger A, El-Khoueiry A, Zhang W, et al. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res. 2011 Sep 1;17(17):5783-92. doi: 10.1158/1078-0432.CCR11-1115.</mixed-citation><mixed-citation xml:lang="en">Gerger A, El-Khoueiry A, Zhang W, et al. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res. 2011 Sep 1;17(17):5783-92. doi: 10.1158/1078-0432.CCR11-1115.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Grage-Griebenow E, Löseke S, Kauth M, et al. Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN-alpha production of plasmacytoid dendritic cells. Immunol Cell Biol. 2007 Jul;85(5):383-90. doi: 10.1038/sj.icb.7100048.</mixed-citation><mixed-citation xml:lang="en">Grage-Griebenow E, Löseke S,  Kauth M, et al. Anti-BDCA-4 (neuropilin-1)  antibody can suppress virus-induced IFN-alpha production of plasmacytoid dendritic cells. Immunol Cell Biol. 2007 Jul;85(5):383-90. doi: 10.1038/sj.icb.7100048.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Guo HF, Vander Kooi CW. Neuropilin Functions as an Essential Cell Surface Receptor. J Biol Chem. 2015 Dec 4; 290(49):29120-6. doi: 10.1074/jbc.R115.687327.</mixed-citation><mixed-citation xml:lang="en">Guo HF, Vander Kooi CW. Neuropilin Functions as an Essential Cell Surface Receptor. J Biol Chem. 2015 Dec 4; 290(49):29120-6. doi: 10.1074/jbc.R115.687327.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hopkins C, Lechien JR, Saussez S. More than ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. 2021 Jan;146:110406. doi: 10.1016/j.mehy.2020.110406.</mixed-citation><mixed-citation xml:lang="en">Hopkins C, Lechien JR, Saussez S. More than ACE2? NRP1 may play a central role in the underlying  pathophysiological  mechanism of  olfactory  dysfunction  in  COVID-19  and  its association with enhanced survival. Med Hypotheses. 2021 Jan;146:110406. doi: 10.1016/j.mehy.2020.110406.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.</mixed-citation><mixed-citation xml:lang="en">Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hippensteel JA, LaRiviere WB, Colbert JF, et al. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217. doi: 10.1152/ajplung.00199.2020.</mixed-citation><mixed-citation xml:lang="en">Hippensteel JA, LaRiviere WB, Colbert JF, et al. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217. doi: 10.1152/ajplung.00199.2020.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hashemi SMA, Thijssen M, Hosseini SY, et al. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Arch Virol. 2021 Aug;166(8):2089-2108. doi: 10.1007/s00705021-05070-6.</mixed-citation><mixed-citation xml:lang="en">Hashemi SMA, Thijssen  M,  Hosseini SY, et al. Human gene polymorphisms and their possible  impact on  the  clinical outcome of SARS-CoV-2 infection. Arch Virol. 2021 Aug;166(8):2089-2108. doi: 10.1007/s00705021-05070-6.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hancock JT, Rouse RC, Stone E, Greenhough A. Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARS-CoV-2. Animals (Basel). 2021 Mar 12;11(3):797. doi: 10.3390/ani11030797.</mixed-citation><mixed-citation xml:lang="en">Hancock JT, Rouse RC, Stone E, Greenhough A. Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARSCoV-2. Animals (Basel). 2021 Mar 12;11(3):797. doi: 10.3390/ani11030797.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Jobe A, Vijayan R. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin. Heliyon. 2021 Oct;7(10):e08251. doi: 10.1016/j.heliyon.2021.e08251.</mixed-citation><mixed-citation xml:lang="en">Jobe A, Vijayan R. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin. Heliyon. 2021 Oct;7(10):e08251. doi: 10.1016/j.heliyon.2021.e08251.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kirschenbaum D, Imbach LL, Ulrich S, et al. Inflammatory olfactory neuropathy in two patients with COVID-19. Lancet. 2020 Jul 18;396(10245):166. doi: 10.1016/S01406736(20)31525-7.</mixed-citation><mixed-citation xml:lang="en">Kirschenbaum D, Imbach  LL,  Ulrich S, et al.  Inflammatory  olfactory  neuropathy in two patients with COVID-19. Lancet. 2020 Jul 18;396(10245):166. doi: 10.1016/S01406736(20)31525-7.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Klaewkla M, Charoenwongpaiboon T, Mahalapbutr P. Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists. J Mol Liq. 2021 Aug 1;335:116537. doi: 10.1016/j.molliq.2021.116537.</mixed-citation><mixed-citation xml:lang="en">Klaewkla   M,   Charoenwongpaiboon T,  Mahalapbutr  P.  Molecular  basis  of   the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists. J Mol Liq. 2021 Aug 1;335:116537. doi: 10.1016/j.molliq.2021.116537.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Li ZL, Buck M. Neuropilin-1 assists SARSCoV-2 infection by stimulating the separation of spike protein domains S1 and S2. bioRxiv [Preprint]. 2021 Jan 19:2021.01.06.425627. doi: 10.1101/2021.01.06.425627. Update in: Biophys J. 2021 Jul 20;120(14):2828-2837.</mixed-citation><mixed-citation xml:lang="en">Li ZL, Buck M. Neuropilin-1 assists SARSCoV-2 infection by  stimulating  the  separation of spike protein domains S1 and S2. bioRxiv [Preprint]. 2021 Jan 19:2021.01.06.425627. doi: 10.1101/2021.01.06.425627. Update in: Biophys J. 2021 Jul 20;120(14):2828-2837.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lyu Z, Jin H, Yan Z, et al. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D. Int J Mol Med. 2020 Oct;46(4):13211334. doi: 10.3892/ijmm.2020.4692.</mixed-citation><mixed-citation xml:lang="en">Lyu Z, Jin H, Yan Z, et al. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D. Int J Mol Med. 2020 Oct;46(4):13211334. doi: 10.3892/ijmm.2020.4692.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lorés-Motta L, van Asten F, Muether PS, et al. A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Pharmacogenet Genomics. 2016 Jan;26(1):207. doi: 10.1097/FPC.0000000000000180.</mixed-citation><mixed-citation xml:lang="en">Lorés-Motta L, van Asten F, Muether PS, et al. A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Pharmacogenet Genomics. 2016 Jan;26(1):207. doi: 10.1097/FPC.0000000000000180.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Moutal A, Martin LF, Boinon L, et al. SARS-CoV-2 spike protein co-opts VEGF-A/ neuropilin-1 receptor signaling to induce analgesia. Pain. 2021 Jan;162(1):243-252. doi: 10.1097/j.pain.0000000000002097.</mixed-citation><mixed-citation xml:lang="en">Moutal A, Martin LF, Boinon L, et al. SARS-CoV-2 spike protein co-opts VEGF-A/ neuropilin-1 receptor signaling to induce analgesia. Pain. 2021 Jan;162(1):243-252. doi: 10.1097/j.pain.0000000000002097.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mayi BS, Leibowitz JA, Woods AT, et al. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021 Jan 4;17(1):e1009153. doi: 10.1371/journal.ppat.1009153.</mixed-citation><mixed-citation xml:lang="en">Mayi BS, Leibowitz JA, Woods AT, et al. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021 Jan 4;17(1):e1009153. doi: 10.1371/journal.ppat.1009153.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Men M, Chen DN, Li JD, et al. Analysis of PLXNA1, NRP1, and NRP2 variants in a cohort of patients with isolated hypogonadotropic hypogonadism. Mol Genet Genomic Med. 2021 Nov;9(11):e1816. doi: 10.1002/mgg3.1816.</mixed-citation><mixed-citation xml:lang="en">Men M, Chen DN, Li JD, et al. Analysis of PLXNA1, NRP1, and NRP2 variants in a cohort of patients with isolated hypogonadotropic hypogonadism. Mol Genet Genomic Med. 2021 Nov;9(11):e1816. doi: 10.1002/mgg3.1816.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura F, Tanaka M, et al. Neuropilin-1 extracellular domains mediate semaphorin D/ III-induced growth cone collapse. Neuron. 1998 Nov;21(5):1093-100. doi: 10.1016/s08966273(00)80626-1.</mixed-citation><mixed-citation xml:lang="en">Nakamura F, Tanaka M, et al. Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron. 1998 Nov;21(5):1093-100. doi: 10.1016/s08966273(00)80626-1.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Parker MW, Xu P, Li X, Vander Kooi CW. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J Biol Chem. 2012 Mar 30;287(14):11082-9. doi: 10.1074/jbc.M111.331140.</mixed-citation><mixed-citation xml:lang="en">Parker MW, Xu P, Li X, Vander Kooi CW. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J Biol Chem. 2012 Mar 30;287(14):11082-9. doi: 10.1074/jbc.M111.331140.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Pollock CE, Sutherland HG, Maher BH, et al. The NRP1 migraine risk variant shows evidence of association with menstrual migraine. J Headache Pain. 2018 Apr 18;19(1):31. doi: 10.1186/s10194-018-0857-z.</mixed-citation><mixed-citation xml:lang="en">Pollock CE, Sutherland HG, Maher BH, et al. The NRP1 migraine risk variant shows evidence of association with menstrual migraine. J Headache Pain. 2018 Apr 18;19(1):31. doi: 10.1186/s10194-018-0857-z.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pellet-Many C, Frankel P, et al. Neuropilins: structure, function and role in disease. Biochem J. 2008 Apr 15;411(2):211-26. doi: 10.1042/BJ20071639.</mixed-citation><mixed-citation xml:lang="en">Pellet-Many C, Frankel P, et al. Neuropilins: structure, function and role in disease. Biochem J. 2008 Apr 15;411(2):211-26. doi: 10.1042/ BJ20071639.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Siri M, Dastghaib S, Zamani M, et al. Autophagy, unfolded protein response, and neuropilin-1 cross-talk in SARS-CoV-2 infection: what can be learned from other coronaviruses. Int J Mol Sci. 2021 Jun 1;22(11):5992. doi: 10.3390/ijms22115992.</mixed-citation><mixed-citation xml:lang="en">Siri M, Dastghaib S, Zamani M, et al. Autophagy, unfolded protein response, and neuropilin-1 cross-talk in SARS-CoV-2 infection: what can be learned from other coronaviruses. Int J Mol Sci. 2021 Jun 1;22(11):5992. doi: 10.3390/ijms22115992.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sun B, Wu XY, Nie M. [SARS-CoV-2 damages male fertility: How and why]. Zhonghua Nan Ke Xue. 2021 Aug;27(8):738-741. Chinese. PMID: 34914248.</mixed-citation><mixed-citation xml:lang="en">Sun B,  Wu XY, Nie M. [SARS-CoV-2 damages male fertility: How and why]. Zhonghua Nan Ke Xue. 2021 Aug;27(8):738-741. Chinese. PMID: 34914248.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Vander Kooi CW, Jusino MA, Perman B, et al. Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6152-7. doi: 10.1073/pnas.0700043104.</mixed-citation><mixed-citation xml:lang="en">Vander Kooi CW, Jusino MA, Perman B, et al. Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6152-7. doi: 10.1073/pnas.0700043104.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Qi L, Chi X, et al. Orchitis: a complicationofsevereacuterespiratorysyndrome (SARS). Biol Reprod. 2006 Feb;74(2):410-6. doi: 10.1095/biolreprod.105.044776.</mixed-citation><mixed-citation xml:lang="en">Xu J, Qi L, Chi X, et al. Orchitis: a complication of severe acute respiratory syndrome (SARS). Biol Reprod. 2006 Feb;74(2):410-6. doi: 10.1095/biolreprod.105.044776.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Zhu R, Xiao T, Liu X. Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses. J Headache Pain. 2020 Feb 11;21(1):13. doi: 10.1186/s10194-020-01087-5.</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Zhu R, Xiao T, Liu X. Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses. J Headache Pain. 2020 Feb 11;21(1):13. doi: 10.1186/s10194-020-01087-5.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
